Utilizing innovative implementation strategies for familial hypercholesterolemia: Implementation outcomes from the IMPACT-FH study
- PMID: 39278768
- PMCID: PMC11606789
- DOI: 10.1016/j.jacl.2024.07.011
Utilizing innovative implementation strategies for familial hypercholesterolemia: Implementation outcomes from the IMPACT-FH study
Abstract
Background: Cascade testing can be highly effective in identifying individuals with familial hypercholesterolemia (FH) and help prevent atherosclerotic cardiovascular disease. The IMPACT-FH cascade testing program offered multiple optimized implementation strategies to improve FH cascade testing uptake.
Objective: Guided by the Conceptual Model of Implementation Research, this study assessed the IMPACT-FH cascade testing program's implementation outcomes.
Methods: Implementation outcomes were assessed qualitatively and quantitatively. Interviews were conducted with 33 IMPACT-FH program participants including 15 probands, 12 relatives, and 6 healthcare professionals (HCPs). Transcripts were analyzed using thematic analysis to investigate implementation outcomes. Descriptive statistics were analyzed for scaled implementation outcome measures asked after interviews.
Results: Participants described adopting strategies offered in the IMPACT-FH program because they presented an opportunity to pursue low-cost FH cascade testing. Participants identified barriers to feasibility including: the complexity of disclosing an FH result and offering strategies, inherent limitations of probands choosing strategies, confusion over testing costs, limitations sharing with relatives' clinicians, discomfort with chatbot technology, and concerns about the workload for HCPs. Participants evaluated the program positively regarding its appropriateness (Mean (M) = 4.70, Standard Deviation (SD) = 0.41), acceptability (M = 4.79, SD = 0.40), and feasibility (M = 4.24, SD = 0.53).
Conclusion: The IMPACT-FH cascade testing program and its strategies were evaluated as valuable to adopt and highly appropriate, acceptable, and feasible by participants. Participants identified areas to enhance the program that could improve FH cascade testing uptake.
Keywords: Cascade testing; Communication; Familial hypercholesterolemia; Genetic testing; Implementation strategies.
Copyright © 2024. Published by Elsevier Inc.
Similar articles
-
Reporting Modifications from the IMPACT-FH Study Using the FRAME-IS.Public Health Genomics. 2025;28(1):205-216. doi: 10.1159/000545974. Epub 2025 Apr 21. Public Health Genomics. 2025. PMID: 40258342
-
Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia.Circ Genom Precis Med. 2021 Feb;14(1):e003120. doi: 10.1161/CIRCGEN.120.003120. Epub 2021 Jan 22. Circ Genom Precis Med. 2021. PMID: 33480803 Free PMC article.
-
Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment.Ont Health Technol Assess Ser. 2022 Aug 23;22(3):1-155. eCollection 2022. Ont Health Technol Assess Ser. 2022. PMID: 36158868 Free PMC article.
-
Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication.Transl Behav Med. 2022 Jul 18;12(7):800-809. doi: 10.1093/tbm/ibac018. Transl Behav Med. 2022. PMID: 35429393 Free PMC article.
-
Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.Atherosclerosis. 2018 Oct;277:383-391. doi: 10.1016/j.atherosclerosis.2018.06.858. Atherosclerosis. 2018. PMID: 30270075 Review.
Cited by
-
Reporting Modifications from the IMPACT-FH Study Using the FRAME-IS.Public Health Genomics. 2025;28(1):205-216. doi: 10.1159/000545974. Epub 2025 Apr 21. Public Health Genomics. 2025. PMID: 40258342
References
-
- Abul-Husn NS, Manickam K, Jones LK, et al. Genetic identification of familial hypercholesterolemia within a single US health care system. Science. 2016;354(6319):aaf7000. - PubMed
-
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082–e1143. - PMC - PubMed
-
- Luirink IK, Wiegman A, Kusters DM, et al. 20-year follow-up of statins in children with familial hypercholesterolemia. New England Journal of Medicine. 2019; - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous